Tata Elxsi Partners with KAVIA AI to Boost GenAI in SDLC

Tata Elxsi Partners with KAVIA AI to Boost GenAI in SDLC

India Pharma Outlook Team | Wednesday, 30 July 2025

Global design and technology services provider Tata Elxsi has partnered strategically with San Francisco-based software 3.0 AI platform KAVIA AI. The company claims that this is designed to manage millions of lines of code and intricate backend systems in a variety of industries, including healthcare.

The complete development lifecycle, from planning and architecture to development, quality control, deployment, and maintenance, is automated by KAVIA AI. With the goal of revolutionizing software quality and time-to-market, the partnership will implement GenAI-assisted automation throughout Tata Elxsi's internal platforms and customer-facing programs. According to the communication note, the collaborative go-to-market will provide the power of GenAI for Software Development Lifecycle (SDLC) to businesses in the media, communications, healthcare, and transportation sectors where engineering dependability is crucial.

Nitin Pai, chief strategy officer, Tata Elxsi, said, “GenAI adoption demands more than tools—it requires a trusted partner to pilot, productise and scale development and deployment workflows. Tata Elxsi brings that trust, backed by 25+ years of proprietary expertise in software engineering across complex, regulated industries, and a deep understanding of deploying GenAI with the appropriate industry-specific guardrails. We deliver not just AI automation and intelligent tools, but real outcomes that go beyond just efficiency to effectiveness and the ‘shift left’ paradigm that enterprises need to scale GenAI in mission-critical environments.”

Also Read: DBT Launches AI-Backed Image Biobanks to Boost Diagnostics

Labeeb Ismail, CEO, KAVIA AI, said, “We’re excited to partner with Tata Elxsi, a company that brings the scale, credibility and delivery discipline needed to realise real-world  AI based-models or AI adoption in large-scale delivery environments. Our platform is built to be enterprise-ready, and Tata Elxsi’s proven delivery record ensures this technology delivers real outcomes to customers.”

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.